Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing. . . . → Read More: Biotechs Partner to Boost mRNA Manufacturing
|
|||||
Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing. . . . → Read More: Biotechs Partner to Boost mRNA Manufacturing A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds A new challenge competition seeks life science research applications for quantum computing that take advantage of the technology’s unique computational properties. . . . → Read More: $50M Challenge Seeks Quantum Life Science Applications Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds. . . . → Read More: Post-Surgical Fluid Cancer Analytics Company Gains $8M Findings from research with lab animals shows a single gene therapy injection delivered with a benign virus helps build new knee cartilage cells and tissue. . . . → Read More: Gene Therapy Shown to Build Knee Cartilage A new analysis shows machine learning algorithms can provide more diagnostic details in liquid biopsies, blood tests to detect and track solid tumor cancers. . . . → Read More: A.I. Shown to Enhance Diagnostics in Liquid Biopsies A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes. . . . → Read More: Fox Foundation Funds New Genetic Variation Targets for Parkinson’s A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer A California state agency is funding a clinical trial of an experimental gene therapy for reducing inflammation in knee joints of people with osteoarthritis. . . . → Read More: State Grant Supports Osteoarthritis Gene Therapy Trial |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |